TransCode Therapeutics, Inc. (RNAZ)
NASDAQ·Healthcare·Biotechnology
$8.45
-0.82%
Mkt Cap $8.87M
No analyst coverage available
We don't have analyst ratings or price target data for TransCode Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.